Efficiency of transcatheter aortic valve implantation in patients with high surgical risk: long-term results of a single-center prospective study

Aim. To study long-term results and predictors of adverse outcomes of transcatheter aortic valve implantation in patients with high surgical risk with severe aortic stenosis.

Material and methods. The prospective single-center study included 140 patients with hemodynamically relevant aortic stenosis who underwent transcatheter aortic valve implantation. We assessed hemodynamic and clinical status, quality of life before and after 1 year of the intervention.

Results. In the long-term follow-up after transcatheter aortic valve implantation, an improvement in the quality of life was noted in both the physical and psychoemotional aspects of health. We did not registered cases of prosthesis dysfunction, repeated surgical interventions one-year survival was 92%. Predictors of adverse outcomes of aortic valve transcatheter implantation were the comorbidity index (odds ratio (OR) 2,8 (1,6-4,9), p<0,001) and, especially, the comorbidity index over 5 points (OR 9,3 (2,9-19,4), p<0,001). Initially low level of quality of life, both in the physical aspect (OR 0,93 (0,86-0,99), p=0,013) and in the psycho-emotional aspect of health (OR 0,94 (0,89-0,99), p=0,027).

Conclusion. Aortic valve transcatheter implantation showed high efficiency in improving the quality of life and reducing mortality in patients with severe aortic stenosis and high surgical risk. Initially low level of quality of life and comorbidity index adversely affect on long-term results.

1. Eveborn GW, Schirmer H, Heggelund G, et al. The evolving epidemiology of valvular aortic stenosis. The Troms0 Study. Heart. 2012;99(6):396-400.

2. Falk V, Baumgartner H, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Journal of Cardio-Thoracic Surgery. 2017;52(4):616-64.

3. Dlez-Villanueva P, Salamanca J, Rojas A, Alfonso F. Importance of frailty and comorbidity in elderly patients with severe aortic stenosis. Journal of Geriatric Cardiology. 2017;14(6):379-82.

4. Walther T, Blumenstein J, van Linden A, Kempfert J. Contemporary management of aortic stenosis: surgical aortic valve replacement remains the gold standard. Heart. 2012;98(Suppl 4):iv23-iv29.

5. Bogachev-Prokofiev AV, Sharifulin RM, Zubarev DD, et al. Short term results of transcatheter aortic valve replacement with transaortal approach. Russian Journal of Cardiology. 2017;22(8):51-8. (In Russ.)

6. Ovcharov MA, Bogachev-Prokophiev AV, Pivkin AN, et al. Commentary to the update 2017 AHA/ACC and ESC/EACTS Guidelines for the management of patients with valvular heart disease. Patologiya krovoobrashcheniya i kardiokhirurgiya = Circulation Pathology and Cardiac Surgery. 2017;21(4):19-22. (In Russ.)

7. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology. 2017;70(2):252-89.

8. Arnold SV, Reynolds MR, Lei Y, et al. Predictors of Poor Outcomes After Transcatheter Aortic Valve Replacement: Results From the PARTNER (Placement of Aortic Transcatheter Valve) Trial. Circulation. 2014;129(25):2682-90.

9. . Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Journal of Cardio-Thoracic Surgery. 2012;42(4):S1-S44.

10. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. European Journal of Cardiothoracic Surgery. 1999;15:813-6.

11. Degroot V, Beckerman H, Lankhorst G, Bouter L. How to measure comorbidity a critical review of available methods. Journal of Clinical Epidemiology. 2003;56(3):221-9.

12. Ware JE. SF-36 Health Survey Update. Spine. 2000;25(24):3130-9.

13. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. New England Journal of Medicine. 2016;374(17):1609-20.

14. Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. The Lancet. 2016;387(10034):2218-25.

15. Holzhey DM, Hansig M, Walther T, et al. Transapical aortic valve implantation - The Leipzig experience. Annals of Cardiothoracic Surgery. 2012;1(2):129-37

16. Walther T, Thielmann M, Kempfert J, et al. One-year multicentre outcomes of transapical aortic valve implantation using the SAPIEN XT valve: the PREVAIL transapical study. European Journal of Cardio-Thoracic Surgery. 2013;43(5):986-92.

17. Dickson VV, Buck H, Riegel B. A qualitative meta-analysis of heart failure self-care practices among individuals with multiple comorbid conditions. J Card Fail. 2011;17(5):413-9.

18. Reynolds MR, Magnuson EA, Wang K, et al. Health-Related Quality of Life After Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis. Journal of the American College of Cardiology. 2012;60(6):548-58.

19. Kamenskaya O, Klinkova A, Loginova I, et al. Factors affecting the quality of life before and after surgery in patients with chronic thromboembolic pulmonary hypertension. Quality of life research. 2017;27(3):747-54.